The surface of the cornea consists of a unique type of non-keratinized epithelial cells arranged in an orderly fashion, and this is essential for vision by maintaining transparency for light transmission. Cornea epithelial cells (CECs) undergo continuous renewal from limbal stem or progenitor cells (LSCs) 1, 2 , and deficiency in LSCs or corneal epitheliumwhich turns cornea into a non-transparent, keratinized skin-like epithelium-causes corneal surface disease that leads to blindness in millions of people worldwide 3 . How LSCs are maintained and differentiated into corneal epithelium in healthy individuals and which key molecular events are defective in patients have been largely unknown. Here we report establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which we found that the transcription factors p63 (tumour protein 63) and PAX6 (paired box protein PAX6) act together to specify LSCs, and WNT7A controls corneal epithelium differentiation through PAX6. Loss of WNT7A or PAX6 induces LSCs into skin-like epithelium, a critical defect tightly linked to common human corneal diseases. Notably, transduction of PAX6 in skin epithelial stem cells is sufficient to convert them to LSC-like cells, and upon transplantation onto eyes in a rabbit corneal injury model, these reprogrammed cells are able to replenish CECs and repair damaged corneal surface. These findings suggest a central role of the WNT7A-PAX6 axis in corneal epithelial cell fate determination, and point to a new strategy for treating corneal surface diseases.
, Benjamin Yu 7, 8 , Shaochen Chen 2, 6 , Xiang-Dong Fu The surface of the cornea consists of a unique type of non-keratinized epithelial cells arranged in an orderly fashion, and this is essential for vision by maintaining transparency for light transmission. Cornea epithelial cells (CECs) undergo continuous renewal from limbal stem or progenitor cells (LSCs) 1, 2 , and deficiency in LSCs or corneal epitheliumwhich turns cornea into a non-transparent, keratinized skin-like epithelium-causes corneal surface disease that leads to blindness in millions of people worldwide 3 . How LSCs are maintained and differentiated into corneal epithelium in healthy individuals and which key molecular events are defective in patients have been largely unknown. Here we report establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which we found that the transcription factors p63 (tumour protein 63) and PAX6 (paired box protein PAX6) act together to specify LSCs, and WNT7A controls corneal epithelium differentiation through PAX6. Loss of WNT7A or PAX6 induces LSCs into skin-like epithelium, a critical defect tightly linked to common human corneal diseases. Notably, transduction of PAX6 in skin epithelial stem cells is sufficient to convert them to LSC-like cells, and upon transplantation onto eyes in a rabbit corneal injury model, these reprogrammed cells are able to replenish CECs and repair damaged corneal surface. These findings suggest a central role of the WNT7A-PAX6 axis in corneal epithelial cell fate determination, and point to a new strategy for treating corneal surface diseases.
Corneal and skin epithelium share many similarities, including a typical morphology of stratified epithelium and maintenance of their stem cells by p63 in the keratin 5/keratin 14 1 (K5/K14)-expressing basal cell layer in limbus and epidermis [4] [5] [6] [7] [8] (Fig. 1a, b and Extended Data Fig. 1a , b). However, there are marked differences between them. Skin epithelial stem cells (SESCs) move upwards from a deep to suprabasal layers vertically during differentiation 9, 10 , where K5 and K14 are replaced by skinspecific K1 and K10 (ref. 11 and Extended Data Fig. 1c, d ). In contrast, LSCs (defined by K19 at the limbus 12 , see Fig. 1a and Extended Data Fig. 1e ) migrate centripetally for several millimetres to the central cornea during which it undergoes differentiation and K5/K14 are replaced by corneal-specific K3 and K12 (refs 13, 14, Fig. 1c and Extended Data Fig. 1f) .
A clear, transparent cornea maintained by CECs is essential for vision. Pathological conversion of CECs into skin-like epithelial cells, as indicated by morphological changes and switches in keratin expression (for example, replacement of cornea-specific K3 and K12 by skin-specific K1 and K10 along with K5 1 cells at the basal layer; see Fig. 1d ), leads to the loss of transparency in the cornea and causes millions of people around the world to suffer from partial or complete blindness 3 , but the underlying mechanism has remained largely unknown.
To elucidate potential disease mechanisms, we successfully developed a feeder-free cell culture protocol to expand LSCs from human donors, enabling us to generate a homogeneous cell population to delineate key factors involved in controlling LSC cell fate determination and CEC differentiation. Proliferating LSCs were characterized by positive p63 and K19 with a high percentage of mitotic marker Ki67 ( Fig. 2a and Extended Data Fig. 1g ). We next established a three-dimensional LSC differentiation protocol to establish a three-dimensional CEC sphere structure from a single LSC within 14 to 18 days, as evidenced by strong expression of the CEC-specific markers K3 and K12 (Fig. 2b) . The threedimensional differentiation sphere was further characterized by key differences in gene expression between LSCs and CECs; the latter showed increased expression of K3 (31.2-fold higher) and K12 (24.7-fold higher) and concomitant decreased expression of K19 (6.2-fold lower, all P , 0.01; see Extended Data Fig. 1h ). We took a similar strategy to expand SESCs and observed strong expression of typical SESC markers p63 and K5 in cultured SESCs (Fig. 2c) . As expected, we detected increased expression of epidermal differentiation markers K1 (16.6-fold higher) and K10 (225.8-fold higher) in three-dimensional differentiated skin epithelial cells (SECs) compared to SESCs (Fig. 2d, Extended Data Fig. 1i, j) .
To identify additional genes uniquely expressed in LSCs, CECs and SESCs, we performed genome-wide gene expression analysis ( Fig. 2e and Extended Data Fig. 2a, b) . Among genes that were differentially expressed, we focused on signalling molecules and transcription factors because of their central roles in cell fate determination and differentiation. We identified that WNT7A and PAX6 were highly expressed in LSCs and CECs when compared to SESCs (PAX6, 8.8-fold higher in LSCs and 12.3-fold higher in CECs, P , 0.001; WNT7A, 4.5-fold higher in LSCs, 6.0-fold higher in CECs, P , 0.001) (Fig. 2e and Extended Data Fig. 2c ). We observed that WNT7A expression precisely mirrored the expression pattern of PAX6 in in vitro LSC and CEC cultures, and in in vivo epithelial layers of cornea and limbus from infant to adult, while both of these genes were undetectable in skin epidermis ( Fig. 2f and Extended Data Fig. 2d) .
To determine the clinical relevance of WNT7A and PAX6 expression in LSCs and CECs, we examined several types of human corneal diseases, corneal epithelium squamous metaplasia, inflammatory keratopathy, trauma and alkaline burn. We observed the localized expression of p63 and K5 at the basal layer ( Fig. 3a and Extended Data Fig. 3) , and the expression of K10 in the suprabasal layer ( Fig. 1d and Extended Data Fig. 3 ). We also found that WNT7A and PAX6 expression, and K3 and K12 expression were conspicuously absent in areas of metaplasia, while they were positive in surrounding corneal epithelium ( Fig. 3a and Extended Data Fig. 3 ). These results suggest cornea epithelial cells were switched to skin-like epithelial cells in patient tissues with these disease conditions.
Wnt molecules are secreted signalling proteins that have a critical role in controlling cell fate decisions and tissue specification 15 . PAX6 is also a well-known control gene for eye development and disease 16 . However, it has remained unclear whether the loss of PAX6 is the cause or the consequence of abnormal skin epidermal differentiation in ocular surface diseases.
To demonstrate that WNT7A and PAX6 are necessary for LSC and CEC cell fate determination and differentiation, we used lentiviral short hairpin RNAs (shRNAs) to knock them down specifically in LSCs. Although LSCs with knockdown of either WNT7A or PAX6 did not change proliferation and morphological properties (Extended Data Fig. 4a ), these treatments significantly diminished the expression of corneal K3 
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and K12 under the three-dimensional differentiation conditions (WNT7A knockdown: 24.7-fold lower in K3, 22.6-fold lower in K12; PAX6 knockdown: 20.8-fold lower in K3, 21.4-fold lower in K12; all P , 0.05), and concurrently, the expression of skin-specific K1 and K10 became more prominent (WNT7A knockdown: 3.9-fold higher in K1 and 5.7-fold higher in K10; PAX6 knockdown: 3.1-fold higher K1 and 6.1-fold higher in K10; all P , 0.05), indicative of more skin-like differentiation (Fig. 3b, c) . Moreover, knockdown of WNT7A reduced PAX6 expression in LSCs (1.8-fold lower, P , 0.001); this repressive effect was even stronger in differentiated CECs (8.0-fold lower, P , 0.01). In contrast, there was no significant difference in WNT7A expression when PAX6 was knocked down in either LSCs or CECs (Fig. 3c and Extended Data Fig. 4b, c) . These results suggest that WNT7A acts upstream of PAX6 during CEC differentiation.
To study further the role of the Wnt signalling pathway in corneal fate determination and differentiation, we investigated the functional requirement of Frizzled receptors, which have been shown to interact and transduce WNT7A signalling based on co-immunoprecipitation 17 . We found that WNT7A interacted strongly with Frizzled 5 (FZD5) in LSCs (Extended Data Fig. 4d, e) , and as predicted, knockdown of FZD5 in LSCs also led to reduced PAX6 expression (1.7-fold lower in LSCs and 3.0-fold lower in differentiated CECs (P , 0.001) (Extended Data Fig. 4f) . Together, these data demonstrated that loss of WNT7A or PAX6 led to a switch of corneal epithelial cells to skin-like epidermal cells and that WNT7A and FZD5 acted as the upstream regulators of PAX6 expression in corneal differentiation.
Given the central role of PAX6 in eye development 16 , we next tested the possibility that engineered expression of PAX6 might be able to convert SESCs into LSC-like cells (Extended Data Fig. 5a ). Indeed, we found that the expression of either PAX6a or PAX6b in SESCs was sufficient to convert them into LSC-like cells, as evidenced by the induced K19 expression on the surface, coincident with the expression of both p63 and PAX6 in the nucleus (Fig. 4a) . When placed in three-dimensional culture, PAX6-transduced SESCs showed dramatic increase in corneal K3 and K12 expression (9.4-fold higher and 72.7-fold higher, all P , 0.05) with concomitant decrease in skin K1 and K10 expression (20.8-fold lower and 20.0-fold lower, all P , 0.01) (Fig. 4b, c and Extended Data Fig. 5b, c) . To obtain global evidence for successful cell fate conversion, we performed gene expression profiling by RNA sequencing (RNAseq) 18 on CECs, SECs and LSCs after knocking down PAX6 and on SESCs transduced with PAX6 upon three-dimensional differentiation. We generated 3 to 7 million reads from each biological sample that were uniquely Data Fig. 6a) . Pairwise comparison demonstrated that the data were very reproducible within the same group of samples (Extended Data Fig. 6b) ; in contrast, when compared between cells with different fates, the data demonstrate remarkable differences based on the statistical cut-off of false discovery rate (FDR) , 0.001 (Extended Data Fig. 6c) . We displayed the entire data sets that recorded the expression of .10,000 genes in various cell types (Fig. 4d) , demonstrating that both induced (red) and repressed (green) genes were clearly co-segregated between CECs and PAX6
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1 SESCs and between PAX6 shRNA-treated LSCs and SECs. These data therefore provided global evidence for a role of the WNT7A-PAX6 axis in cell fate conversion from SESCs to CECs. Together, these data suggest that defects in the WNT7A-PAX6 axis are likely to be responsible for metaplastic conversion of corneal cells to skin epidermal-like cells in corneal diseases in humans (shown in Fig. 4e) , although further studies need to be performed to determine the significance of the WNT7 and PAX6 axis in corneal epithelial differentiation.
Finally, we tested the treatment and repair potential of SESCs with engineered expression of PAX6 (Extended Data Fig. 7a-c) for corneal epithelial defects in a rabbit LSC deficiency model (Extended Data Fig. 7f ), which mimics a common corneal disease condition in humans. We showed that rabbit SESCs with PAX6 transduction formed a continuous sheet of epithelial cells with positive staining of corneal-specific K3 and K12 (Fig. 5a ) and successfully repaired epithelium defect of the entire corneal surface to restore and maintain normal cornea clarity and transparency for over 3 months (Fig. 5b-g and Extended Data Fig. 8) . By following the time course of corneal epithelial surface repair using GFPlabelled PAX6
1 SESCs, we observed that these PAX6-reprogrammed SESCs were initially only located at the limbal region and then moved progressively towards the central cornea with corresponding areas of restored cornea clarity (Extended Data Fig. 9a) . Importantly, these grafted cells were indeed able to repopulate limbus as evidenced by culture and re-isolation of PAX6
1 SESCs from limbal region (Extended Data Fig. 9b ). Notably, these reprogrammed SESCs were capable of repairing large corneal epithelium defects after repeated corneal epithelial scraping (Extended Data Fig. 9c) . In marked contrast, transplanting rabbit LSCs with PAX6 knockdown (Extended Data Fig. 7a, d , e) onto denuded corneal surface resulted in a K10
1 skin-like epithelium with opacity and vascularization (Fig. 5f ). Together, these data demonstrate that SESCs with PAX6 expression are able to trans-differentiate into corneal-like epithelium and repair corneal surface defects.
In summary, this work establishes the feasibility of expanding LSCs under feeder-free conditions and its therapeutic potential, and demonstrates key roles of WNT7A and PAX6 in corneal lineage specification. Importantly, SESCs or other cell types converted into a corneal fate by PAX6 expression may serve as a potential source for corneal surface repair and regeneration, particularly in patients with total LSC deficiency. This would overcome a major feasibility problem in using a patient's own reprogrammed LSCs for transplantation, thus pointing to a potential therapeutic strategy for treating many common corneal diseases in humans.
METHODS SUMMARY
LSCs and SESCs were isolated from rabbits and human donors in feeder-free media and differentiated in the three-dimensional culture conditions. Histology, immunohistochemistry and immunocytochemistry were carried out on paraffin sections as well as on cultured cells. Gene expression microarray, RNA-seq and quantitative PCR (qPCR) were performed using total RNA isolated from LSCs, SESCs and CECs.
Lentiviral RNA interference and engineered-expression study of WNT7A, PAX6 and FZD5 were carried out in LSCs and SESCs. Cell transplantation of LSCs and SESCs was performed on animal models of corneal injury. Detailed information is provided in the supplement.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Human pathology samples. Corneal epithelium squamous metaplasia and all other tissues were obtained as de-identified surgical specimens, fixed in 5% formalin, embedded into paraffin, sectioned and stained for immunofluorescence studies. Isolation and culture of limbal stem cells and skin epidermal stem cells. Postmortem human eyeballs were obtained from eye banks and limbus regions were taken and washed in cold PBS with 100 international units (IU) penicillin and 100 mg ml 21 streptomycin, and cut into small pieces. Cell clusters were obtained by 0.2% collagenase IV digestion at 37 uC for 2 h, single cells were obtained by further digestion with 0.25% trypsin-EDTA at 37 uC for 15 min. Primary cells were seeded on plastic plates coated with 2% growth factor reduced Matrigel (354230, BD Biosciences). Limbal stem cells from GFP-labelled rats and rabbits were isolated and cultured using the same method as for human LSCs.
Human epidermis was obtained from donor skin biopsy of eye lids, and hair follicles were removed under microscope. Primary human and rabbit epidermal stem cells were isolated from interfollicular epidermis using the same method as described for human limbal stem cells. Culture medium was as follows: DMEM/F12 and DMEM (1:1) with 1/100 penicillin-streptomycin, 10% fetal bovine serum, 10 ng ml 21 EGF, 5 mg ml 21 insulin, 0.4 ug ml 21 hydrocortisone, 10 210 M cholera toxin and 2 3 10 29 M 3,39,5-triiodo-L-thyronine. All cells used in the current manuscript are from primary cultured cells made in our laboratories, and mycoplasma contamination tests were routinely carried out and were negative. In vitro three-dimensional differentiation protocol. Three-dimensional differentiation was performed on a 24-well plate or an 8-well chamber. In brief, dissociated single stem cells were embedded in matrigel at 2 3 10 4 cells per 50 ml gel. Three-dimensional structures were formed after 14-18 days culture in a differentiation medium CnT-30 (limbal stem cell differentiation) or CnT-02 (skin epidermal stem cell differentiation) (Cellntec). Immunofluorescence and laser confocal microscopy. To detect the localization of proteins in cultured cells, cells were fixed with 4% paraformaldehyde for 20 min, then permeablized with 0.3% Triton X-100-PBS for 5 min twice and blocked in PBS solution containing 5% bovine serum albumin and 0.3% TritonX-100%, followed by an overnight incubation in primary antibodies at 4 uC. After three washes in PBS, cells were incubated with secondary antibody. Cell nuclei were counterstained with DAPI (49,6-diamidino-2-phenylindole). For immunofluorescence of paraffinembedded tissue sections, de-paraffinization was performed, followed by the same immunofluorescence protocol described above.
The following antibodies were used: mouse anti-p63 monoclonal antibody, rabbit anti-K5 monoclonal antibody, mouse anti-K10 monoclonal antibody, mouse anti-K14 monoclonal antibody with biotin labelled, mouse anti-K19 monoclonal antibody, (MA1-21871, RM2106S0, MS611P0, MS115B0, MS1902P0, Thermo Fisher Scientific), rabbit anti-PAX6 polyclonal antibody (PRB-278P, Covance), mouse anti-K1 monoclonal antibody (sc-376224, Santa Cruz), Rabbit anti-WNT7A polyclonal antibody, mouse anti-K3/K12 monoclonal antibody, rabbit anti-K12 monoclonal antibody (ab100792, ab68260, ab124975, Abcam), mouse anti-Ki67 monoclonal antibody (550609, BD BioSciences), anti-GFP rabbit monoclonal antibody and anti-GFP mouse monoclonal antibody (G10362, A11120, Invitrogen). The secondary antibodies, AlexaFluor-488-or 568-conjugated anti-mouse or rabbit immunoglobulin-G (IgG) (Invitrogen) were used at a dilution of 1:500. Images were obtained using an Olympus FV1000 confocal microscope. Quantitative PCR. RNA was isolated using an RNeasy kit (Qiagen) and subjected to on-column DNase digestion. Complementary DNA synthesis was performed using a superscript III reverse transcriptase kit according to the manufacturer's instructions (Invitrogen). qPCR was performed by 40-cycle amplification using gene-specific primers (Extended Data Table 1 ; top) and a Power SYBR Green PCR Master Mix on a 7500 Real Time PCR System (Applied Biosystems). Measurements were performed in triplicates and normalized to endogenous GAPDH levels. Relative fold change in expression was calculated using the DDCT method (cycle threshold (CT) values , 30). Data are shown as mean 6 s.d. based on three replicates. Genome-wide gene expression microarray and data analysis. Total RNA was isolated from LSCs, SESCs and differentiated CECs from three-dimensional differentiation assay. Gene expression microarray analysis was performed using an Illumina human genome microarray system, with each sample in biological replicate (n 5 2 per group; Human HT-12 v4 Expression BeadChip; Illumina, San Diego, California). Raw data were deposited into the GEO database under accession number GSE32145. Expression-level data were generated by the Illumina BeadStudio version 3.4.0 and normalized using quartile normalization. Probes whose expression level exceeded a threshold value of 64 in at least one sample were considered detected. The threshold value was found by inspection from the distribution plots of log 2 expression levels. Detected probes were sorted according to their q value, which is the smallest false discovery rate (FDR) at which the probe is called significant. FDR was evaluated using significance analysis of microarrays and its implementation in the official statistical package sam 19 . To avoid false positive calls due to spuriously small variances, the percentile of standard deviation values used for the exchangeability factor s0 in the regularized t-statistic was set to 50. We combined the LESC and CEC samples into one group of four samples, and looked for differentially expressed genes between this group and SESCs samples. The top 100 significant genes in this comparison are presented in Extended Data Fig. 2 . All genes in this figure are significant at the FDR level of 0.01 or less. A heatmap was created using in-house hierarchical clustering software, and colours qualitatively correspond to fold changes. RNA-seq and hierarchical cluster analysis. Total RNA was purified by a Picropure RNA isolation kit (Life Technology). RNA-seq was performed as described previously 20 . In brief, 600 ng of total RNA was first converted to cDNA by superscript III first strand synthesis kit with primer Biotin-B-T. The cDNA was purified by NucleoSpin Gel and PCR Clean-Up Kit column (Clontech) to remove free primers and enzyme. Then terminal transferase (NEB) was applied to block the terminal of a cDNA 39 end. Streptavidin-coaged magnetic beads (Life Technology) were further applied to isolate cDNAs. After RNA degradation by sodium hydroxide, second-strand cDNA was synthesized by random priming with primer A-N8. The second strand cDNA was eluted from beads by heat denaturing. The cDNA was then used as template to construct libraries by amplifies with barcode primers and primer PB. The sequencing was done on Hiseq 2000 system.
Hierarchical cluster analysis was performed with cluster and Java TreeView 21 . The raw data were first filtered using default parameters provided by the program Cluster. The filtered data were further adjusted by log transformation, genes and arrays were centred by median, and then both gene and array were hierarchically clustered with euclidean and average linkage. The hierarchical trees and gene matrix were visualized and generated by Java Treeview. Lentiviral RNA interference and PAX6 transduction. Lentiviral shRNAs targeting PAX6, WNT7A and FZD5 genes were either cloned into pLKO.1 plasmid between Age I and EcoR I or purchased directly from Sigma. shRNAs targeting sequences for gene-specific knockdowns were as follows: PAX6, CGTCCATCTT TGCTTGGGAAA and AGTTTGAGAGAACCCATTATC; WNT7A, CGTGCT CAAGGACAAGTACAA and GCGTTCACCTACGCCATCATT; FZD5, CGCG AGCCCTTCGTGCCCATT and TCCTAAGGTTGGCGTTGTAAT. We used a lentiviral pLKO.1-puro Non-Target shRNA control plasmid encoding a shRNA that did not target any known genes from any species as a negative control in all gene knockdown experiments (Sigma).
Lentiviral shRNA particles were prepared according to a previous described protocol 22 . In brief, replication-incompetent lentiviral particles were packaged in 293T cells by co-transfection of shRNA constructs with packaging mix (pCMVdR8.2 and pCMV-VSVG at a 9:1 ratio). Virus was collected two times at 48 h and 72 h post transfection.
For transduction, PAX6a open reading frame (ORF) was PCR amplified from cDNAs purchased from Thermo Scientific (MHS6278-202756612) and inserted into pLenti CMV-GFP Puro vector between BamH1 and BsrG1. PAX6b was generated by PCR-mediated point mutation strategy with primers PAX6 InF and PAX6 InR (Extended Data Table 1; top). For GFP labelling, pLenti CMV-GFP Hygro (656-4) purchased from Addgene was used. The lentiviral particles were packaged by co-transfection with packaging plasmids psPax2 and pMD2.G.
For lentiviral infection, cells were infected for 16-20 h with fresh media containing individual virus and polybrene at a final concentration of 8 mg ml
21
. The infected cells were further selected by 2 mg ml 21 uromycin for 48 h or 200 mg ml 21 hygromycin for 72 h. Western blot analysis and co-immunoprecipitation. For western blot analysis, cells were washed once with PBS and then collected in cell lysis buffer (50 mM TrisHCl, pH 6.8; 2% SDS; 10% Glycerol; 100 mM DTT). Protein concentration was quantified by Nanodrop and Bromophenol blue was added to a final concentration of 0.1%, then 25 mg of total lysate was fractionated on a 4-12% NUPAGE gel (Life Technology). Proteins were transferred to a nitrocellulose membrane at 100 V for 1 h. The membrane was blocked with 5% milk and probed with relevant antibodies and mouse anti-b-actin monoclonal antibody (A5316, Sigma).
To detect interaction between FZD5 and WNT7A, a 10-cm dish of limbal stem cells at 90% confluence was collected; the cell pellet was resuspended in 700 ml of co-immunoprecipitation (Co-IP) buffer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 2.5 mM MgCl 2 , 0.5% NP-40, 13 proteinase inhibitor) and incubated on ice for 20 min, then centrifuged at 13,000 r.p.m. at 4 uC for 20 min. The 600 ml of supernatant were aliquoted into two pre-chilled Eppendorf tubes, 5 mg of rabbit anti-FZD5 monoclonal antibody (#5266, Cell Signaling) or WNT7A antibodies was added to each tube and incubated at 4 uC overnight. Protein A/G magnetic beads (50 ml, Thermo Fisher) were added to each tube, and incubated at 4 uC for 2 h, washed with a Co-IP buffer and eluted in 13 SDS sample buffer (Life Technology) at 70 uC. The input and elutes were fractionated on 4-12% NUPAGE gel and blotted with FZD5 and WNT7A antibodies. 
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